Quince settles $16.4M EIB debt for $5.5M, eliminates debt overhang

Quince Therapeutics, Inc.

Paid $5.5M to settle ~$16.4M in EIB debt obligations, a discount of roughly $10.9M.
All obligations under the Finance Documents are fully satisfied and discharged.
CEO says settlement removes a substantial constraint on pursuing strategic alternatives.
Company continues restructuring and evaluation of strategic alternatives including M&A.

item 1.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.